Oric Pharmaceuticals Inc. (ORIC) Social Stream
ORIC PHARMACEUTICALS INC (ORIC) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ORIC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 6 | $52 | $31 | $39.333 | $8.04 | 389.22% |
| 2022-01-26 | 6 | $52 | $31 | $38.166 | $8.04 | 374.7% |
| 2022-03-22 | 7 | $33 | $7 | $18 | $8.04 | 123.88% |
| 2022-04-04 | 6 | $33 | $10 | $19 | $8.04 | 136.32% |
| 2022-05-11 | 6 | $17 | $10 | $13.666 | $8.04 | 69.98% |
| 2022-08-12 | 6 | $17 | $10 | $14 | $8.04 | 74.13% |
| 2022-11-08 | 6 | $15 | $10 | $12.5 | $8.04 | 55.47% |
| 2022-12-09 | 6 | $16 | $10 | $13.666 | $8.04 | 69.98% |
| 2023-03-17 | 6 | $16 | $10 | $13.75 | $8.04 | 71.02% |
| 2023-03-21 | 6 | $15 | $10 | $13.5 | $8.04 | 67.91% |
| 2023-03-23 | 6 | $16 | $14 | $15 | $8.04 | 86.57% |
| 2023-04-05 | 5 | $16 | $8 | $13.833 | $8.04 | 72.05% |
| 2023-05-09 | 6 | $16 | $8 | $13.833 | $8.04 | 72.05% |
| 2023-05-10 | 6 | $15 | $8 | $13.5 | $8.04 | 67.91% |
| 2023-08-13 | 6 | $15 | $8 | $13.333 | $8.04 | 65.83% |
| 2023-08-16 | 7 | $27 | $8 | $15.142 | $8.04 | 88.33% |
| 2023-09-05 | 7 | $27 | $13 | $15.857 | $8.04 | 97.23% |
| 2023-10-22 | 8 | $27 | $13 | $15.625 | $8.04 | 94.34% |
| 2023-11-13 | 8 | $27 | $14 | $16.625 | $8.04 | 106.78% |
| 2023-12-11 | 8 | $27 | $12 | $16.375 | $8.04 | 103.67% |
| 2023-12-13 | 8 | $27 | $12 | $16.25 | $8.04 | 102.11% |
The Trend in the Analyst Price Target
Over the past 37 months, ORIC's average price target has gone down $28.92.
Over the past 39 weeks, ORIC's average upside potential has been 141.27%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-17 | 6 | 16 | 10 | 13.750 | 4.56 | 201.54% |
| 2023-03-23 | 5 | 16 | 10 | 14.166 | 5.20 | 172.42% |
| 2023-05-10 | 6 | 15 | 8 | 13.500 | 5.14 | 162.65% |
| 2023-10-26 | 8 | 27 | 14 | 16.625 | 6.48 | 156.56% |
| 2023-11-13 | 8 | 27 | 14 | 16.625 | 6.13 | 171.21% |
ORIC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 8 | 0 | 0 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
ORIC's average broker recommendation rating improved by 0.33 over the prior 23 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how ORIC PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 2124.58% of that group.
- In the context of all US stocks, ORIC PHARMACEUTICALS INC's average analyst price target is higher than 576.92% of them.
- In terms of how ORIC PHARMACEUTICALS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1669.73% of that group.
- ORIC has a greater number of analysts covering the stock than 1978.98% of stocks in the small market cap category.
In the Pharmaceutical Products industry, PLRX, CALT, and RNA are the three stocks most similar to ORIC PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for ORIC? Use POWR Ratings for clearer insight into price direction.